Unlock the full potential of next-generation dermatological therapies with this definitive, authoritative guide that seamlessly bridges advanced formulation chemistry with practical, disease-targeted strategies for drug delivery.

Lipidic nanocarriers represent a transformative approach to cutaneous drug delivery by enhancing localized transport, therapeutic efficacy, and safety profiles. This volume systematically examines the structural architecture, formulation chemistry, and preparation methodologies of nanovesicular carriers. Through dedicated coverage of dermal and transdermal delivery platforms, it bridges theoretical principles with actionable strategies to address complex drug administration challenges. Additionally, the text explores targeted nanomedicines for specific cutaneous pathologies, including dermatitis, acne vulgaris, psoriasis, and skin malignancies, as well as liposomal platforms, analyzing their structural characteristics and the precise mechanisms governing topical and transdermal penetration. Ultimately, this text serves as an authoritative resource for researchers, clinical practitioners, and pharmaceutical developers advancing targeted cutaneous therapeutics.

Readers will find the volume:

• Showcases the latest advancements in drug delivery systems designed specifically to overcome the challenges of skin penetration and enhance therapeutic outcomes;
• Provides targeted delivery strategies tailored for a wide range of dermatological conditions, including psoriasis, eczema, acne, and skin cancers, bridging pharmaceutical innovation with clinical relevance;
• Explores the journey of dermatological formulations, addressing both preclinical development and translational hurdles for effective skin-targeted therapy;
• Addresses formulation stability, safety assessment, and regulatory challenges unique to dermatological drug delivery, making it a critical reference for product development and commercialization.

Audience

Pharmaceutical scientists, dermatologists, analytical scientists, and healthcare professionals, academics, and researchers actively involved in pharmaceutical products and processes related to drug and gene delivery, as well as biomedical applications.

Neeraj Mishra, PhD is a Professor at the Amity Institute of Pharmacy, Amity University, Gwalior, India with more than 20 years of teaching and research experience. He has published more than 100 articles in international journals and conferences of repute, ten books, and 25 book chapters. He has also been granted three international patents and two Indian patents. His research focuses on novel drug delivery systems, localized drug delivery, targeted and controlled drug delivery of nanocarriers and microparticles for the treatment of breast and colon cancer and neurodegenerative disorders.

Nimisha, PhD is an Associate Professor in the Amity Institute of Pharmacy, Amity University Lucknow Campus, India with more than 16 years of teaching and research experience. She has presented papers in more than 50 national and international conferences and holds a granted Indian patent and an additional published patent. Her research interests include novel drug delivery systems, dermatological disorders,wound healing, nanovesicular systems for herbal phytoconstituents, and nanocrystals for the treatment of breast and skin cancer.

Tanweer Haider, PhD is a Research Scientist at Intas Pharmaceutical Ltd. Biopharma Division, Ahmedabad, India. He has made significant contributions to his field, with more than 30 research articles in renowned journals, 12 book chapters, and one edited book to his credit. His research interests focus on novel drug delivery systems, targeted and controlled drug delivery, particulate and vesiculate nanocarriers, nanomedicine, tumor targeting, targeted drug delivery, and quality by design.

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy, Vivekananda Global University, Jaipur, India. He has published one authored book, eleven edited books, five chapters, and 20 review papers. His areas of interest include nanoformulation, blockchain, IoT, machine learning, cancer, artificial intelligence, big data, and neuroscience.